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Caspase activation during virus infection: more than just the kiss of death?
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-Shakespeare’s Hamlet, Act II, Scene ii.
To facilitate their replication, viruses utilize many host
cell factors including receptors, enzymes, transcription fac-
tors, organelles, and membranes. In short, they commandeer
the cellular environment. At the same time, viruses must
circumvent cellular responses that have evolved to limit
virus replication. Apoptosis, the genetically and biochemi-
cally controlled process of cell death, is one such cellular
response that limits both the time and cellular machinery
available for virus replication. Viruses employ a variety of
strategies to evade apoptosis, and this is the subject of many
good review articles (e.g., Cuconati and White, 2002;
Everett and McFadden, 2002). The existence of multiple
viral anti-apoptotic gene products across diverse groups of
viruses suggests that apoptosis is something viruses should
avoid at all costs. However, as is often the case in biological
systems, the relationship between virus replication and
apoptosis is actually much more complex. It is now recog-
nized that some viruses directly utilize components of the
apoptotic pathway to facilitate their replication. This novel
and seemingly paradoxical strategy of virus replication, in
the face of a very effective anti-viral response, is the subject
of this review.The caspases
The key effector proteins activated during apoptosis are
the caspases, or cysteine-dependent aspartate-specific
proteases (Alnemri et al., 1996). The primary function of
caspases is to cleave cellular substrates, which results in0042-6822/$ - see front matter. Published by Elsevier Inc.
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E-mail address: sbest@niaid.nih.gov (S.M. Best).amplification of the apoptotic process and the stepwise
dismantling of the cell. To date, there are more than 280
known proteins targeted by caspases for cleavage (Fischer et
al., 2003). For cleavage to occur, the target protein must
possess a caspase cleavage site containing an aspartic acid
(D) residue as well as be recognized by the enzyme’s
cysteine side chain which catalyzes the peptide-bond cleav-
age (Stennicke et al., 2002). Caspases exist in the cell as
inactive pro-caspases or zymogens, which are themselves
cleaved and activated in response to apoptotic stimuli.
Apoptotic caspases are activated in a proteolytic cascade.
Pro-caspases containing a longer prodomain (caspases 2, 8,
9, and 10) are activated first and are thus called initiator
caspases. Initiator caspases then cleave and activate zym-
ogens with a shorter prodomain called executioner caspases
(caspases 3, 6, and 7). Caspase 3 cleaves the majority of
cellular substrates during apoptosis and is also responsible
for cleaving viral proteins. Caspases 7, 6, and 2 have also
been implicated in the cleavage of viral protein substrates
(Al-Molawi et al., 2003; Ele´oue¨t et al., 2000; Grand et al.,
2002).The viruses
A prevailing view is that viruses encode inhibitors of
caspase activity to escape apoptosis and thereby prolong
their replication cycle. However, several viruses adopt a
seemingly counterintuitive strategy and utilize caspases to
cleave their own proteins. The evolutionary advantage to the
virus of caspase-mediated cleavage of one of its own
proteins is not always immediately apparent. For example,
it is unclear how caspase cleavage of the nucleocapsid
proteins of both Influenza A virus (Zhirnov et al., 1999)
and transmissible gastroenteritis coronavirus (Ele´oue¨t et al.,
2000), the capsid protein of feline calicivirus (Al-Molawi et
al., 2003), and infected cell protein no.22 of herpes simplex
virus 1 (Munger et al., 2003) benefits the virus. However,
because mutation of a single D residue would eliminate the
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sites suggests a selection for caspase-mediated cleavage in
virus replication or pathogenesis. In other cases, the cleav-
age of viral proteins has a more defined role in replication.
Examples of these are discussed below and involve the
cleavage of the viral nonstructural protein, which may
function in the transcriptional regulation of virus or host-
cell genes.Caspases as facilitators of protein nuclear transport and
transcriptional regulation
Aleutian mink disease parvovirus
Aleutian mink disease parvovirus (ADV) is a unique
member of the genus parvovirus that exhibits two distinct
patterns of virus replication. Infection of Crandell feline
kidney (CrFK) cells in vitro or newborn mink kits in vivo is
acute, with permissive and cytopathic virus replication.
However, infection of adult mink leads to restricted, non-
cytopathic infection of lymph node macrophages resulting
in low levels of viral replication and viral persistence.
Similar to many other virus infections, permissive infec-
tion of ADV induces apoptosis and the addition of caspase
inhibitors to infected cells blocks the apoptotic cascade.
Surprisingly, inhibition of specific caspases results in a
dramatic decrease in virus yield suggesting a requirement
for caspase activity during replication (Best et al., 2002). It
has recently been demonstrated that NS1, the major non-
structural protein of ADV, is cleaved by executioner cas-
pases early in virus replication (Best et al., 2003). NS1 is
responsible for many of the replication functions including
viral and cellular gene transcription, viral DNA replication,
and capsid assembly. NS1 is also highly cytotoxic to cells,Fig. 1. Caspase-mediated control of ADV replication. Following entry and uncoati
translated to produce NS1 (2). During permissive replication (left hand panel), N
fragment required for the efficient translocation of NS1 into the nucleus (solid arro
DNA replication ( ) and the control of gene expression (4), as well as
or is tightly controlled, lack of NS1 cleavage results in restricted virus replicatio
(dotted arrow), and subsequent low levels of viral DNA replication, gene expresscausing apoptosis following infection or transfection. Cas-
pase-mediated cleavage of NS1 occurs at two sites, imme-
diately following residues D227 and D285 (Best et al.,
2003). Mutation of these NS1 caspase cleavage sites abro-
gates virus replication by severely impairing translocation of
NS1 to the nucleus of infected cells. However, the C-
terminal caspase cleavage product translocates efficiently
to the nucleus following expression, as does the full-length
NS1 in the presence of the C-terminal product. As parvo-
virus NS1 molecules must oligomerize to translocate to the
nucleus, it is likely that caspase cleavage of a portion of
ADV NS1 generates an abbreviated NS1 molecule capable
of binding the full-length NS1 and taxiing it into the nucleus
(Fig. 1). If caspase activation and apoptosis are limited after
ADV infection in vivo, nuclear translocation and function of
NS1 in DNA replication and control of viral gene expres-
sion may be restricted. The tight regulation of caspase
activity by the cell or by ADV may therefore be a mech-
anism involved in the restriction of virus replication and
may contribute to the persistent infection of adult mink.
Hepatitis C virus
The flavivirus, hepatitis C virus (HCV), causes chronic
hepatitis in 50–84% of infected individuals. Its single-
stranded RNA genome is translated essentially as a single
open reading frame (ORF), with the single large polypro-
tein cleaved by host and viral proteases to produce four
structural and six nonstructural proteins. Of the nonstruc-
tural proteins, NS5A is a multifunctional protein of 447
amino acids (aa) involved in the enhancement of viral
pathogenesis (reviewed in Reyes, 2002). NS5A is cleaved
by caspases at two residues, D154 and D389, to yield
NS5A:155–389, a central fragment with both the N- and C-
terminal portions removed (Satoh et al., 2000). Uncleavedng of ADV into the host cell (1), early mRNA ( ) is transcribed and
S1 is cleaved by activated caspases (C) (3) to produce an abbreviated NS1
w). Once in the nucleus, NS1 can efficiently function in its roles during viral
the packaging of infectious virions (5). If caspase activation does not occur
n (right hand panel) due to inefficient translocation of NS1 to the nucleus
ion, and infectious progeny.
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located on the cytoplasmic side of the endoplasmic reticu-
lum. However, cleavage to NS5A:155–389 unmasks a
nuclear localization sequence (NLS) and removes a cyto-
plasmic retention sequence (CRS), enabling translocation to
the cell nucleus. NS5A:155–389 also demonstrates tran-
scriptional activation that can be regulated by protein kinase
A (Satoh et al., 2000). The transcriptional activating do-
main of NS5A:155–389 maps to a region between aa 228
and 284, while full-length NS5A cannot function as a
transcriptional activator (Fukuma et al., 1998). Together,
these findings suggest that caspase-mediated cleavage of
NS5A is required to enable its nuclear translocation and
subsequent host-cell gene regulation.
The caspase-cleaved NS5A:155–389 contains multiple
regions that may be involved in pathogenesis through
interactions with cellular proteins in the nucleus. For exam-
ple, NS5A is able to directly interact with and negatively
regulate the transcriptional regulator p53 tumor suppressor
protein resulting in attenuated interferon and apoptotic
responses to virus infection (reviewed in Reyes, 2002).
Nuclear NS5A also induces expression of IL-8, an inhibitor
of interferon-a activity. The region of NS5A generated via
caspase-mediated cleavage also contains two of the three
Bcl-2 homology (BH) domains of NS5A. These domains
are involved in the inhibition of apoptosis and may function
by interacting with the pro-apoptotic molecule Bax in the
nucleus (Chung et al., 2003). Hence, caspase-mediated
cleavage of NS5A may serve as a ‘sensor’ for caspase
activity and the activation of the viral anti-apoptotic and
perhaps anti-interferon responses that occur in the nucleus
of infected cells.
Adenoviruses
The adenoviruses (Ad) are a large group of DNA viruses
capable of causing both acute and persistent infections in
humans and other animals, depending on the serotype. The
relatively large genome (36 kb) is organized into early and
late transcription units. The early transcription units E1AFig. 2. A common theme for caspase-mediated cleavage of viral nonstructural prote
Ad 12 E1A at multiple sites (amino acid positions indicated by arrows), to yield cle
interacting with the transcriptional machinery of cells. Caspase-mediated cleavage
transcriptional regulation. The question mark indicates that the actual cellular locand E1B encode proteins involved in cellular transforma-
tion and transactivation of both cellular and viral transcrip-
tion. Translation of E1A results in the production of two
major proteins (12S and 13S) that are both strong inducers
of apoptosis in mammalian cells via multiple pathways.
However, the pro-apoptotic effect of E1A is modulated
during infection by apoptosis-inhibitory effects of E1B
proteins (reviewed in Frisch and Mymryk, 2002). Apopto-
sis has been shown to positively affect virus release (Chiou
and White, 1998), but it is unclear if apoptosis has a more
direct role in virus replication. Following transfection of the
E1A proteins from Ad2 or Ad12, both 12S and 13S are
cleaved by caspases at multiple sites, resulting in progres-
sive cleavage from the N-termini (Grand et al., 2002). This
cleavage disrupts the interactions of E1A with cellular
transcriptional-regulating proteins that bind to its N-termi-
nus but not to the C-terminus (Grand et al., 2002), suggest-
ing a potential regulatory role of caspases in E1A-mediated
gene expression.
Following infection with Ad5, E1A is also proteolytical-
ly cleaved by caspases. However, cleavage of both the E1A
proteins, as well as cellular proteins normally cleaved
during apoptosis, is limited and is cell-type dependent
(Grand et al., 2002). This type of limited caspase activity
affecting some proteins while leaving other vital cellular
proteins intact has been observed during non-apoptotic
events such as cell cycle control, cellular proliferation, and
differentiation (Fischer et al., 2003). While the mechanisms
for this limited caspase activity remain to be elucidated, the
possibility that caspase-mediated cleavage of Ad E1A has a
function in virus replication, cellular transformation, or viral
persistence is intriguing. Studies on the molecular relation-
ships between Ad E1A and the infected cell may lead to
further insight on the role of caspase activity in non-
apoptotic events.
Influenza A virus
The orthomyxovirus Influenza A is yet another virus that
utilizes caspases for virus replication. Infection with influ-ins? Activated caspases cleave ADV NS1 and HCV NS5A at two sites, and
avage fragments capable of localizing to the nucleus (indicated in green) and
of viral nonstructural proteins may be an important mechanism involved in
alization of the caspase cleaved product is not yet known.
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two influenza proteins, NS1 and PB1-F2, promote apoptosis
induction. However, the consequences of apoptosis for virus
replication and pathogenesis have not been well understood.
Similar to our results for ADV, the addition of peptide
inhibitors of caspases to influenza A-infected cell cultures
not only inhibited virus-induced apoptosis, but also im-
paired virus replication (Wurzer et al., 2003). The require-
ment for caspase activity operated at late steps in virus
replication, facilitating the export of viral ribonucleoprotein
complexes from the nucleus for packaging into progeny
virions in the cytoplasm of infected cells. The most likely
explanation for the role of caspase activation in this case
was in the caspase-dependent increase in the diffusion limit
of nuclear pores (Wurzer et al., 2003). Although this is not a
direct utilization of caspases for the cleavage of viral
proteins and subsequent replication, activation of specific
caspases is an absolute requirement in this case and is not
simply a byproduct of cell stress and apoptosis.Beyond cell death
As mentioned previously, caspase activation is involved
in many cellular processes, apoptotic as well as non-apo-
ptotic. The latter includes inflammation, cell cycle control,
cell differentiation, and hematopoiesis. The activation of
caspases in these non-apoptotic processes must be tightly
regulated so that it does not culminate in the death of the
cell. This level of control is just now beginning to be
appreciated. The degree of regulation is also likely to be
host cell-type dependent. Many viruses are dependent on the
stage of cell cycle or cellular differentiation for precise
temporal expression of host proteins required for replica-
tion. It is now being realized that caspases are important
host cell proteases utilized by viruses. This direct require-
ment renders caspase activation a possible point of control
or restriction of virus replication, both in apoptotic and non-
apoptotic cells.
In the literature to date, the caspase targets for ADV,
HCV, and Ad are nonstructural proteins involved in the
transcriptional regulation of viral and cellular genes (Fig. 2).
Thus, a common theme for the restriction or regulation of
virus replication may be caspase-mediated cleavage of viral
transcriptional regulators. The replication of a potentially
lytic virus (e.g., ADV) that requires caspases for efficient
gene transcription may be restricted if, due to tight control at
the cellular level, caspase activation does not occur follow-
ing infection. In turn, this restriction of replication may
enable the establishment of virus persistence. If such cleav-
age of viral proteins during replication is a wider phenom-
enon among virus families, it may have escaped observation
due to the subsequent inhibition of apoptosis by the cleaved
protein itself (e.g., HCV NS5A, Satoh et al., 2000), by
additional virally encoded proteins (e.g., Ad5), or by cellu-
lar inhibition of caspase activity. Nevertheless, the directfacilitation of virus replication by caspases may be an
important and novel mechanism that contributes to the
replication strategies of other important viruses. Though
initially counterintuitive, the employment of the anti-viral
apoptotic response is yet another clever strategy adapted by
viruses to thrive in the host environment.References
Al-Molawi, N., Beardmore, V.A., Carter, M.J., Kass, G.E.N., Roberts,
L.O., 2003. Caspase-mediated cleavage of the feline calicivirus cap-
sid protein. J. Gen. Virol. 84, 1237–1244.
Alnemri, E.S., Livingston, D.J., Nicholson, D.W., Salvesen, G., Thorn-
berry, N.A., Wong, W.W., Yuan, J., 1996. Human ICE/CED-3 protease
nomenclature. Cell 87, 171.
Best, S.M., Wolfinbarger, J.B., Bloom, M.E., 2002. Caspase activation is
required for permissive replication of Aleutian mink disease parvovirus
in vitro. Virology 292, 224–234.
Best, S.M., Shelton, J.F., Pompey, J.M., Wolfinbarger, J.B., Bloom, M.E.,
2003. Caspase cleavage of the nonstructural protein NS1 mediates rep-
lication of Aleutian mink disease parvovirus. J. Virol. 77, 5305–5312.
Chiou, S.-K., White, E., 1998. Inhibition of ICE-like proteases inhibits
apoptosis and increases virus production during adenovirus infection.
Virology 244, 108–118.
Chung, Y.-L., Sheu, M.-L., Yen, S.-H., 2003. Hepatitis C virus NS5A as a
potential viral Bcl-2 homologue interacts with Bax and inhibits apopto-
sis in hepatocellular carcinoma. Int. J. Cancer 107, 63–73.
Cuconati, A., White, E., 2002. Viral homologs of Bcl-2: role of apoptosis in
the regulation of virus infection. Genes Dev. 16, 2465–2478.
Ele´oue¨t, J.-F., Slee, E.A., Saurini, F., Castagne´, N., Poncet, D., Garrido, C.,
Solary, E., Martin, S.J., 2000. The viral nucleocapsid protein of trans-
missible gastroenteritis coronavirus (TGEV) is cleaved by caspase-6
and -7 during TGEV-induced apoptosis. J. Virol. 74, 3975–3983.
Everett, H., McFadden, G., 2002. Poxviruses and apoptosis: a time to die.
Curr. Opin. Microbiol. 5, 395–402.
Fischer, U., Janicke, R.U., Schulze-Osthoff, K., 2003. Many cuts to ruin:
a comprehensive update of caspase substrates. Cell Death Differ. 10,
76–100.
Frisch, S.M., Mymryk, J.S., 2002. Adenovirus-5 E1A: paradox and para-
digm. Nat. Rev., Mol. Cell Biol. 3, 441–452.
Fukuma, T., Enomoto, N., Marumo, F., Satoh, C., 1998. Mutations in the
interferon-sensitivity determining region of hepatitis C virus and tran-
scriptional activity of the nonstructural region 5A protein. Hepatology
28, 1147–1153.
Grand, R.J.A., Schmeiser, K., Gordon, E.M., Zhang, X., Gallimore, P.H.,
Turnell, A.S., 2002. Caspase-mediated cleavage of adenovirus early
region 1A proteins. Virology 301, 255–271.
Munger, J., Hagglund, R., Roizman, B., 2003. Infected cell protein no.22 is
subject to proteolytic cleavage by caspases activated by a mutant that
induces apoptosis. Virology 305, 364–370.
Reyes, G.R., 2002. The nonstructural NS5A protein of hepatitis C virus: an
expanding, multifunctional role in enhancing hepatitis C virus patho-
genesis. J. Biomed. Sci. 9, 187–197.
Satoh, S., Hirota, M., Noguchi, T., Hijikata, M., Handa, H., Shimotonot,
K., 2000. Cleavage of hepatitis C virus nonstructural protein 5A by a
caspase-like protease(s) in mammalian cells. Virology 270, 476–487.
Stennicke, H.R., Ryan, C.A., Salvesen, G.S., 2002. Reprival from execu-
tion: the molecular basis of caspase inhibition. Trends Biochem. Sci. 27,
94–101.
Wurzer, W.J., Planz, O., Ehrhardt, C., Giner, M., Silberzahn, T., Pleschka,
S., Ludwig, S., 2003. Caspase 3 activation is essential for efficient
influenza virus propagation. EMBO J. 22, 2717–2728.
Zhirnov, O.P., Konakova, T.E., Garten, W., Klenk, H.-D., 1999. Caspase-
dependent N-terminal cleavage of influenza nucleocapsid protein in
infected cells. J. Virol. 73, 10158–10163.
